Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Shanghai Kindly Medical Instruments
1501Shanghai INT Medical Instruments Co., Ltd. engages in the research and development, manufacture, and sale of cardiovascular interventional medical devices in Mainland China, Europe, the United States, and internationally. The company offers digital inflation devices; cardiac valves balloon inflation catheter; guiding catheter used to provide a channel for introducing balloon catheter, guidewire or other treatment devices; micro catheter to support the placement of guide wires; guidewire; angiography catheter used to inject and infuse contrast media and fluid; Y-connector pack used in PTCA surgery; inflation device used to inflate the balloon of dilating the vessel or placing the stent in the vessel; manifold for single use; and manifold kit. It also provides pressure bandage used to assist compression hemostasis; angiography syringe for single use; stopcocks used for pressure monitoring tubing during surgery; sterile seldinger needle used to puncture into the artery; pressure transducer for single use; extension tube for pressure monitoring; introducer set; joint intervention kit; introducer tool kit used in percutaneous vertebroplasty; and distal access catheter. In addition, the company offers medical accessories, such as check value, needle free connector, male Luer locks, bi-stopper, Heparian cap, flush device, flow regulator, and drip chamber assembly; other products, including disposable respirator, 3D medical surgical fask mask, vaginal dilator, foley catheter, infusion pumps, disposable automatic umbilical cord clamps, infusion connector and accessory for single use, and burette infusion sets without a needle. It serves medical device manufacturers and other customers. The company was formerly known as Shanghai Kindly Medical Instruments Co., Ltd. and changed its name to Shanghai INT Medical Instruments Co., Ltd. in January 2024. The company was founded in 2006 and is headquartered in Shanghai, China. Address: No. 925 Jin Yuan Yi Road, Shanghai, China, 201803
Analytics
Zielpreis von Wall Street
272.68 HKDKGV
25.2252Dividendenrendite
1.05 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 1501
Dividenden-Analyse 1501
Dividendenwachstum über 5 Jahre
–Kontinuierliches Wachstum
1 JahrAusschüttungsquote 5-Jahres-Durchschnitt
34 %Verlauf der Dividende 1501
Bewertung der Aktie 1501
Finanzen 1501
Ergebnisse | 2019 | Dynamik |